Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05310409 · ClinicalTrials.gov registry record
PAN-PROMISE to Detect Post-ERCP Pancreatitis Symptoms
A clinical trial of Post-ERCP Acute Pancreatitis, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 700
- Enrollment target
- 2
- Study locations
NCT05310409: Completed study of Post-ERCP Acute Pancreatitis, sponsored by University of Pennsylvania.
NCT05310409 is a study of Post-ERCP Acute Pancreatitis that has completed, run by University of Pennsylvania. The registered enrollment target is 700 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05310409, a study of Post-ERCP Acute Pancreatitis, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 700 participants
- Enrollment target
- 2
- Study locations
Study Summary
The aim of this study is to use a validated patient-reported outcome measure to evaluate how many patients have symptoms of pancreatitis after ERCP and how it correlates with their quality of life and productivity.
Primary Outcome
will define post-ERCP pancreatitis using the Cotton Consensus Criteria with a 3 physician adjudication committee.
Conditions Studied
Study Locations (2)
California
- University of California, San Francisco - San Francisco
Pennsylvania
- University of Pennsylvania Health System - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2020-09-15 |
| Est. Completion | 2023-01-01 |
What the finished NCT05310409 record still lists
NCT05310409 is an observational study that tracks outcomes without assigning an intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Post-ERCP Acute Pancreatitis appearing as the primary indexed condition, and to 0 interventions.
NCT05310409 reports a single indexed study location in California, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05310409 about?
NCT05310409 is a clinical study titled "PAN-PROMISE to Detect Post-ERCP Pancreatitis Symptoms". The aim of this study is to use a validated patient-reported outcome measure to evaluate how many patients have symptoms of pancreatitis after ERCP and how it correlates with their quality of life and productivity.
What is the current status of trial NCT05310409?
This trial is currently completed. The enrollment target is 700 participants. The study started on 2020-09-15. Estimated completion is 2023-01-01.
What conditions does trial NCT05310409 study?
This clinical trial studies the following conditions: Post-ERCP Acute Pancreatitis.
Who is sponsoring clinical trial NCT05310409?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05310409 being conducted?
This trial has 2 study locations across California, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post-ERCP Acute Pancreatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI